Browse Virus and Neut Antibodies

13 Items Found In Antibodies / Page 1 of 1

Anti-2019-nCoV S-hIgG1 Neutralizing Antibody

Catalog Number

RD90422A

Host

Human

Reactivity

SARS-COV2

Application

Neutralization,ELISA

Variation

Quantity

Add to Cart More details

Antibodies Immobilized Recombinant 2019-nCoV S-trimer Protein (C-6His) at 5.0 ug/mL (100 μL/well) can bind Anti-2019-nCoV S-hIgG1 Neutralizing Antibody (8A5), the EC50 is 2.9 ng/mL.

Anti-2019-nCoV S-mIgG1 Neutralizing Antibody

Catalog Number

RD90423A

Host

Mouse

Reactivity

SARS-COV2

Application

Neutralization,ELISA

Variation

Quantity

Add to Cart More details

Antibodies Immobilized Recombinant 2019-nCoV S-trimer Protein (C-6His) at 5.0 μg/mL (100 uL/well) can bind Anti-2019-nCoV S-mIgG1 Neutralizing Antibody (8A5), the EC50 is 4.43 ng/mL.

Anti-2019-nCoV S-cIgG1 Neutralizing Antibody

Catalog Number

RD90424A

Host

Cynomolgus

Reactivity

SARS-COV2

Application

Neutralization,ELISA

Variation

Quantity

Add to Cart More details

Antibodies Immobilized Recombinant 2019-nCoV S-trimer Protein (C-6His) at 5.0 ug/mL (100 uL/well) can bind Anti-2019-nCoV S-cIgG1 Neutralizing Antibody (8A5), the EC50 is 14.7 ng/mL.

Anti-2019-nCoV Spike Neutralizing Antibody

Catalog Number

RD90425A

Host

Mouse

Reactivity

SARS-COV2

Application

Neutralization,ELISA

Variation

Quantity

Add to Cart More details

Antibodies Anti-2019-nCoV Spike Neutralizing Antibody(4A3) can block Human ACE2 Protein (His Tag) and 2019-nCoV Spike Protein (RBD, mFc Tag) interaction, the IC50 for this effect is 231 ng/mL.

Anti-2019-nCoV Spike Neutralizing Antibody

Catalog Number

RD90426A

Host

Mouse

Reactivity

SARS-COV2

Application

Neutralization,ELISA

Variation

Quantity

Add to Cart More details

Antibodies Anti-2019-nCoV Spike Neutralizing Antibody(5A7) can block Human ACE2 Protein (His Tag) and 2019-nCoV Spike Protein (RBD, mFc Tag) interaction, the IC50 for this effect is 231 ng/mL.

Anti-2019-nCoV S-IgM Neutralizing Antibody

Catalog Number

RD90427A

Host

Human

Reactivity

SARS-COV2

Application

Neutralization,ELISA

Variation

Quantity

Add to Cart More details

Antibodies Immobilized Recombinant 2019-nCoV S-trimer Protein (C-6His) at 5.0 ug/mL (100 uL/well) can bind Anti-2019-nCoV S-IgM Neutralizing Antibody (8A5), the EC50 is 10.1 ng/mL.

Anti-2019-nCoV S-IgA Neutralizing Antibody

Catalog Number

RD90428A

Host

Human

Reactivity

SARS-COV2

Application

Neutralization,ELISA

Variation

Quantity

Add to Cart More details

Antibodies Immobilized Recombinant 2019-nCoV S-trimer Protein (C-6His) at 5.0 ug/mL (100 uL/well) can bind Anti-2019-nCoV S-IgA Neutralizing Antibody (8A5), the EC50 is 397 ng/mL.

Anti-SARS-CoV-2 Spike RBD (CB6 biosimilar) Neutralizing Antibody

Catalog Number

RD90429A

Host

Human

Reactivity

SARS-COV2

Application

Neutralization,ELISA

Variation

Quantity

Add to Cart More details

Antibodies Immobilized Recombinant 2019-nCoV Spike Protein (RBD, C-mFc Tag)(Active) at 2.0 ug/mL (100 uL/well) can bind Anti-SARS-CoV-2 Spike RBD (CB6 biosimilar) Neutralizing Antibody in a linear range of 0.24~15.62 ng/mL.

Anti-AcmNPV Envelope glycoprotein gp64/AcmNPV-gp64 Neutralizing Antibody

Catalog Number

RD90445A

Host

Mouse

Reactivity

AcMNPV

Application

microneutralization,ELISA

Variation

Quantity

Add to Cart More details

Antibodies AcmNPV Envelope glycoprotein gp64 antibody neutralization activity is Measured by microneutralization assay in vitro.
The virus microneutralization (MN) test was performed on SF9 cells infected with recombinant baculovirus (autographa californica nucleopolyhedrovirus) under treatment of serial dilutions of neutralizing antibody. The infection was neutralized by increasing concentrations of AcmNPV Envelope glycoprotein gp64/AcmNPV-gp64 Neutralizing Antibody. The IC50 is typically 0.25~1.0 g/mL.

Anti-Enterovirus 71 VP1 Neutralizing Antibody

Catalog Number

RD90458A

Host

Human

Reactivity

Enterovirus 7

Application

microneutralization,ELISA

Variation

Quantity

Add to Cart More details

Antibodies The neutralization activity of Anti-Enterovirus 71 VP1 Neutralizing Antibody is Measured by Microneutralization test in vitro.
The cytopathic effect of RD cells (10e5/well) induced by 100CCID50 EV71 genogroup C4 is neutralized by increasing concentrations of Anti-Enterovirus 71 VP1 Neutralizing Antibody. The IC50 is typically 0.7~1.3 g/mL.
NA: No antibody added.

Anti-Enterovirus 71 VP4 Neutralizing Antibody

Catalog Number

RD90459A

Host

Mouse

Reactivity

Enterovirus 7

Application

microneutralization,ELISA

Variation

Quantity

Add to Cart More details

Antibodies The neutralization activity of Anti-Enterovirus 71 VP4 Neutralizing Antibody is Measured by Microneutralization test in vitro.
The cytopathic effect of RD cells (10e5/well) induced by 100CCID50 EV71 genogroup C4 is neutralized by increasing concentrations of Anti-Enterovirus 71 VP4 Neutralizing Antibody. The IC50 is typically 4~8 g/mL.
NA: No antibody added.

Anti-Human respiratory syncytial virus(RSV) Fusion glycoprotein/RSV-F Neutralizing Antibody

Catalog Number

RD90522A

Host

Rabbit

Reactivity

RSV

Application

microneutralization,ELISA

Variation

Quantity

Add to Cart More details

Anti-MERS-CoV(NCoV/Novel coronavirus) Spike Monoclonal Antibody

Catalog Number

RD90534A

Host

Rabbit

Reactivity

MERS-CoV

Application

microneutralization,ELISA

Variation

Quantity

Add to Cart More details

Antibodies Measured by its ability to inhibit infection of Caco-2 cells induced by MERS-CoV pseudovirus. The ED50 for this effect is 2.5~11 ng/mL.